Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Pharmaceutical industry marketing: understanding its impact on women's health.

Sufrin CB, Ross JS.

Obstet Gynecol Surv. 2008 Sep;63(9):585-96. doi: 10.1097/OGX.0b013e31817f1585. Review.

PMID:
18713478
2.

The role of marketing in pharmaceutical research and development.

Calfee JE.

Pharmacoeconomics. 2002;20 Suppl 3:77-85. Review.

PMID:
12457428
3.

Benefits and harms of direct to consumer advertising: a systematic review.

Gilbody S, Wilson P, Watt I.

Qual Saf Health Care. 2005 Aug;14(4):246-50. Review.

4.

Observations and advertising: controversies in the prescribing of hormone replacement therapy.

Katz A.

Health Care Women Int. 2003 Dec;24(10):927-39. Review.

PMID:
14742130
5.

Does direct-to-consumer advertising affect patients' choice of pain medications?

Liu Y, Doucette WR.

Curr Pain Headache Rep. 2008 Apr;12(2):89-93. Review.

PMID:
18474186
6.
7.

Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.

Schetky DH.

Child Adolesc Psychiatr Clin N Am. 2008 Jan;17(1):113-25, ix-x. Review.

PMID:
18036482
8.

Psychology in the prescription era: building a firewall between marketing and science.

Antonuccio DO, Danton WG, McClanahan TM.

Am Psychol. 2003 Dec;58(12):1028-43. Review.

PMID:
14664691
9.

Direct to consumer advertising in healthcare: history, benefits, and concerns.

Adeoye S, Bozic KJ.

Clin Orthop Relat Res. 2007 Apr;457:96-104. Review.

PMID:
17310934
10.

Ethics in pharmaceutical advertising.

Lober CW.

Dermatol Clin. 1993 Apr;11(2):285-8. Review.

PMID:
8477540
11.
12.

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Krieger N, Löwy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudillière JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G.

J Epidemiol Community Health. 2005 Sep;59(9):740-8. Review.

13.

Barriers to women's health: why is it so hard for women to stay healthy?

Ogburn T, Voss C, Espey E.

Med Clin North Am. 2008 Sep;92(5):993-1009, ix. doi: 10.1016/j.mcna.2008.05.002. Review.

PMID:
18721650
14.
15.

Academic detailing.

Shankar PR, Jha N, Piryani RM, Bajracharya O, Shrestha R, Thapa HS.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):126-34. Review.

PMID:
21209521
16.

Women's experiences of cardiac pain: a review of the literature.

O'Keefe-McCarthy S.

Can J Cardiovasc Nurs. 2008;18(3):18-25. Review. Erratum in: Can J Cardiovasc Nurs. 2009;19(2):3.

PMID:
18727283
17.

Assessing new interventions in women's health.

Hills RK, Daniels J.

Best Pract Res Clin Obstet Gynaecol. 2006 Oct;20(5):713-28. Epub 2006 Jun 5. Review.

PMID:
16750935
18.

Pharmaceutical drug promotion: how it is being practiced in India?

Lal A.

J Assoc Physicians India. 2001 Feb;49:266-73. Review.

PMID:
11225144
19.

The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand.

Norey E, Simone TM, Mousa SA.

Appl Health Econ Health Policy. 2008;6(2-3):93-102. doi: 10.2165/00148365-200806020-00002. Review.

PMID:
19231903
20.

Direct-to-consumer advertising of pharmaceuticals: developed countries experiences and Turkey.

Semin S, Aras S, Guldal D.

Health Expect. 2007 Mar;10(1):4-15. Review.

PMID:
17324191
Items per page

Supplemental Content

Write to the Help Desk